224 related articles for article (PubMed ID: 17095272)
1. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
Ivanov AA; Palyulin VA; Zefirov NS
J Mol Graph Model; 2007 Jan; 25(5):740-54. PubMed ID: 17095272
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
3. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
Piersen CE; True CD; Wells JN
Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists.
Ivanov AA; Baskin II; Palyulin VA; Piccagli L; Baraldi PG; Zefirov NS
J Med Chem; 2005 Nov; 48(22):6813-20. PubMed ID: 16250640
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
[TBL] [Abstract][Full Text] [Related]
6. Adenosine receptor modelling. A1/A2a selectivity.
Tuccinardi T; Ortore G; Manera C; Saccomanni G; Martinelli A
Eur J Med Chem; 2006 Mar; 41(3):321-9. PubMed ID: 16427161
[TBL] [Abstract][Full Text] [Related]
7. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding.
Barbhaiya H; McClain R; Ijzerman A; Rivkees SA
Mol Pharmacol; 1996 Dec; 50(6):1635-42. PubMed ID: 8967987
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling of purinergic receptor P2Y12 and interaction with its antagonists.
Zhan C; Yang J; Dong XC; Wang YL
J Mol Graph Model; 2007 Jul; 26(1):20-31. PubMed ID: 17110146
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site.
Gutiérrez-de-Terán H; Centeno NB; Pastor M; Sanz F
Proteins; 2004 Mar; 54(4):705-15. PubMed ID: 14997566
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of adenosine receptors: new results and trends.
Martinelli A; Tuccinardi T
Med Res Rev; 2008 Mar; 28(2):247-77. PubMed ID: 17492754
[TBL] [Abstract][Full Text] [Related]
13. Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.
Sherbiny FF; Schiedel AC; Maass A; Müller CE
J Comput Aided Mol Des; 2009 Nov; 23(11):807-28. PubMed ID: 19757091
[TBL] [Abstract][Full Text] [Related]
14. Adenosine receptors: protein and gene structure.
Olah ME; Ren H; Stiles GL
Arch Int Pharmacodyn Ther; 1995; 329(1):135-50. PubMed ID: 7639615
[TBL] [Abstract][Full Text] [Related]
15. CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
Berkhout TA; Blaney FE; Bridges AM; Cooper DG; Forbes IT; Gribble AD; Groot PH; Hardy A; Ife RJ; Kaur R; Moores KE; Shillito H; Willetts J; Witherington J
J Med Chem; 2003 Sep; 46(19):4070-86. PubMed ID: 12954060
[TBL] [Abstract][Full Text] [Related]
16. Homology modelling and binding site mapping of the human histamine H1 receptor.
Kiss R; Kovári Z; Keseru GM
Eur J Med Chem; 2004 Nov; 39(11):959-67. PubMed ID: 15501545
[TBL] [Abstract][Full Text] [Related]
17. A highly conserved tryptophan residue in the fourth transmembrane domain of the A adenosine receptor is essential for ligand binding but not receptor homodimerization.
Suzuki T; Namba K; Yamagishi R; Kaneko H; Haga T; Nakata H
J Neurochem; 2009 Aug; 110(4):1352-62. PubMed ID: 19558453
[TBL] [Abstract][Full Text] [Related]
18. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
[TBL] [Abstract][Full Text] [Related]
19. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
20. Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocket.
Castonguay LA; Weng Y; Adolfsen W; Di Salvo J; Kilburn R; Caldwell CG; Daugherty BL; Finke PE; Hale JJ; Lynch CL; Mills SG; MacCoss M; Springer MS; DeMartino JA
Biochemistry; 2003 Feb; 42(6):1544-50. PubMed ID: 12578367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
